Pierre Fabre Laboratories Strengthen R&D Portfolio and Announce the Acquisition of the Worldwide Rights for PFL-721 and PFL-241
PFL-721 and PFL-241 are mutant-specific EGFR inhibitors with best-in-class potential, being developed…
Celldex Presents Data Demonstrating Profound Long Term Improvement in Angioedemain Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI 2025
June 14, 2025 10:48 ET | Source: Celldex Therapeutics, Inc. 77% of…
Vaxart Announces Preliminary Results of Annual Meeting of Stockholders
June 13, 2025 16:52 ET | Source: Vaxart, Inc. SOUTH SAN FRANCISCO,…
23andMe Reaches Agreement for Sale of Business to TTAM Research Institute Following Final Round of Bidding in Court-Approved Sale Process
June 13, 2025 16:22 ET | Source: 23andMe, Inc. TTAM Commits to…
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 13, 2025 16:01 ET | Source: Nurix Therapeutics, Inc. SAN FRANCISCO,…
Mogo Applies to Extend the Expiry Dates of Certain Warrants
VANCOUVER, British Columbia--(BUSINESS WIRE)--Mogo Inc. (NASDAQ:MOGO) (TSX:MOGO) (“Mogo” or the “Company”), a…
JZXN Raises Funds through Convertible Notes to Acquire Bitcoin, Initiating a Strategic Layout of Thousands of Bitcoins
HANGZHOU, China, June 11, 2025 /PRNewswire/ -- JZXN Holdings, Inc. (NASDAQ: JZXN; the…
ACM Research to Participate at the 15th Annual ROTH London Conference
June 13, 2025 16:05 ET | Source: ACM Research, Inc. FREMONT, Calif.,…
Monolithic Power Systems Announces Second Quarter 2025 Dividend
June 13, 2025 16:01 ET | Source: Monolithic Power Systems, Inc. KIRKLAND,…